167 related articles for article (PubMed ID: 12935312)
1. Structure-activity relationship of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone).
Watanabe K; Morinaka Y; Iseki K; Watanabe T; Yuki S; Nishi H
Redox Rep; 2003; 8(3):151-5. PubMed ID: 12935312
[TBL] [Abstract][Full Text] [Related]
2. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
[TBL] [Abstract][Full Text] [Related]
3. Pulse radiolysis study on free radical scavenger edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one). 2: A comparative study on edaravone derivatives.
Hata K; Lin M; Katsumura Y; Muroya Y; Fu H; Yamashita S; Nakagawa H
J Radiat Res; 2011; 52(1):15-23. PubMed ID: 21139328
[TBL] [Abstract][Full Text] [Related]
4. Edaravone inhibits lipid peroxidation in neonatal hypoxic-ischemic rats: an in vivo microdialysis study.
Noor JI; Ueda Y; Ikeda T; Ikenoue T
Neurosci Lett; 2007 Feb; 414(1):5-9. PubMed ID: 17280782
[TBL] [Abstract][Full Text] [Related]
5. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
6. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats.
Tomatsuri N; Yoshida N; Takagi T; Katada K; Isozaki Y; Imamoto E; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Jan; 13(1):105-9. PubMed ID: 14654979
[TBL] [Abstract][Full Text] [Related]
7. Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion.
Yamamoto Y; Yanagisawa M; Tak NW; Watanabe K; Takahashi C; Fujisawa A; Kashiba M; Tanaka M
Redox Rep; 2009; 14(6):251-8. PubMed ID: 20003710
[TBL] [Abstract][Full Text] [Related]
8. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
[TBL] [Abstract][Full Text] [Related]
9. Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemia-induced brain injury in neonatal rats.
Ikeda T; Xia YX; Kaneko M; Sameshima H; Ikenoue T
Neurosci Lett; 2002 Aug; 329(1):33-6. PubMed ID: 12161256
[TBL] [Abstract][Full Text] [Related]
10. A theoretical investigation on DPPH radical-scavenging mechanism of edaravone.
Wang LF; Zhang HY
Bioorg Med Chem Lett; 2003 Nov; 13(21):3789-92. PubMed ID: 14552780
[TBL] [Abstract][Full Text] [Related]
11. Pulse radiolysis study on free radical scavenger edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one).
Lin M; Katsumura Y; Hata K; Muroya Y; Nakagawa K
J Photochem Photobiol B; 2007 Nov; 89(1):36-43. PubMed ID: 17822914
[TBL] [Abstract][Full Text] [Related]
12. Improvement of postischemic dopaminergic dysfunction by edaravone, a free radical scavenger.
Akiyama Y; Miwa S
J Pharmacol Sci; 2007 May; 104(1):99-102. PubMed ID: 17452805
[TBL] [Abstract][Full Text] [Related]
13. Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone.
Fujisawa A; Yamamoto Y
Redox Rep; 2016 May; 21(3):98-103. PubMed ID: 26196041
[TBL] [Abstract][Full Text] [Related]
14. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
[TBL] [Abstract][Full Text] [Related]
15. The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radical.
Abe S; Kirima K; Tsuchiya K; Okamoto M; Hasegawa T; Houchi H; Yoshizumi M; Tamaki T
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):186-91. PubMed ID: 14758002
[TBL] [Abstract][Full Text] [Related]
16. Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats.
Toyota E; Miyamoto Y; Imai K; Neishi Y; Kawamoto T; Okura H; Yoshida K
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):e20-5. PubMed ID: 19473343
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic efficacy of edaravone in extensively burned rats.
Koizumi T; Tanaka H; Sakaki S; Shimazaki S
Arch Surg; 2006 Oct; 141(10):992-5. PubMed ID: 17043277
[TBL] [Abstract][Full Text] [Related]
18. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat.
Yagi H; Horinaka S; Matsuoka H
J Cardiovasc Pharmacol; 2005 Jul; 46(1):46-51. PubMed ID: 15965354
[TBL] [Abstract][Full Text] [Related]
19. Edaravone attenuates hydroxyl radical stress and augmented angiotensin II response in diabetic rats.
Saini AK; Patel RJ; Sharma SS; H S AK
Pharmacol Res; 2006 Jul; 54(1):6-10. PubMed ID: 16545576
[TBL] [Abstract][Full Text] [Related]
20. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases.
Higashi Y; Jitsuiki D; Chayama K; Yoshizumi M
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):85-93. PubMed ID: 18221078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
